139 related articles for article (PubMed ID: 9010862)
1. Neurologic, pulmonary, and cutaneous toxicities of high-dose chemotherapy.
Armstrong T; Rust D; Kohtz JR
Oncol Nurs Forum; 1997; 24(1 Suppl):23-33. PubMed ID: 9010862
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy and cutaneous toxicities: implications for oncology nurses.
Viale PH
Semin Oncol Nurs; 2006 Aug; 22(3):144-51. PubMed ID: 16893743
[TBL] [Abstract][Full Text] [Related]
3. Outpatient chemotherapy: telephone triage for symptom management.
Anastasia PJ; Blevins MC
Oncol Nurs Forum; 1997; 24(1 Suppl):13-22. PubMed ID: 9010861
[TBL] [Abstract][Full Text] [Related]
4. Neurologic complications of cancer chemotherapy.
Sul JK; Deangelis LM
Semin Oncol; 2006 Jun; 33(3):324-32. PubMed ID: 16769421
[TBL] [Abstract][Full Text] [Related]
5. [Neurotoxicity and dermatologic toxicity of cancer chemotherapy].
Nakane M
Gan To Kagaku Ryoho; 2006 Jan; 33(1):29-33. PubMed ID: 16410694
[TBL] [Abstract][Full Text] [Related]
6. Long-term effects of cancer chemotherapy.
Sunnenberg TD; Kramer B
Compr Ther; 1985 Sep; 11(9):58-67. PubMed ID: 4042597
[TBL] [Abstract][Full Text] [Related]
7. Toxic effects of multiple anticancer drugs on skin.
Kamil N; Kamil S; Ahmed SP; Ashraf R; Khurram M; Ali MO
Pak J Pharm Sci; 2010 Jan; 23(1):7-14. PubMed ID: 20067860
[TBL] [Abstract][Full Text] [Related]
8. New chemotherapy treatment options and implications for nursing care.
Berg DT
Oncol Nurs Forum; 1997; 24(1 Suppl):5-12. PubMed ID: 9010860
[TBL] [Abstract][Full Text] [Related]
9. Potential mechanisms of interferon neurotoxicity.
Bender CM; Monti EJ; Kerr ME
Cancer Pract; 1996; 4(1):35-9. PubMed ID: 8788769
[TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal toxicity of chemotherapeutic agents.
Mitchell EP
Semin Oncol; 2006 Feb; 33(1):106-20. PubMed ID: 16473649
[TBL] [Abstract][Full Text] [Related]
11. Antiemetic therapy in patients receiving cancer chemotherapy.
Marek C
Oncol Nurs Forum; 2003; 30(2):259-71. PubMed ID: 12692660
[TBL] [Abstract][Full Text] [Related]
12. An overview of chemotherapy toxicities.
Peters BG
Top Hosp Pharm Manage; 1994 Jul; 14(2):59-88. PubMed ID: 10136204
[TBL] [Abstract][Full Text] [Related]
13. Nursing implications of mylotarg: a novel antibody-targeted chemotherapy for CD33+ acute myeloid leukemia in first relapse.
Shannon-Dorcy K
Oncol Nurs Forum; 2002 May; 29(4):E52-9. PubMed ID: 12011919
[TBL] [Abstract][Full Text] [Related]
14. Vesicant extravasation part I: Mechanisms, pathogenesis, and nursing care to reduce risk.
Sauerland C; Engelking C; Wickham R; Corbi D
Oncol Nurs Forum; 2006 Nov; 33(6):1134-41. PubMed ID: 17149396
[TBL] [Abstract][Full Text] [Related]
15. [Neurotoxicity with cytostatic therapy: a review].
Cerny T; Meier C
Schweiz Med Wochenschr; 1989 Aug; 119(34):1137-47. PubMed ID: 2554491
[TBL] [Abstract][Full Text] [Related]
16. Phase I trial of paclitaxel, carboplatin, and methotrexate with granulocyte colony-stimulating factor and leucovorin in advanced transitional cell carcinoma.
Edelman MJ; Meyers FJ; Houston J; Lauder I
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-68-S15-71. PubMed ID: 9346226
[TBL] [Abstract][Full Text] [Related]
17. Leukemia during pregnancy.
Ramirez-Smiley M; Ingle B
Oncol Nurs Forum; 1995 Oct; 22(9):1363-8. PubMed ID: 8539177
[TBL] [Abstract][Full Text] [Related]
18. Psychosocial impact of cutaneous toxicities associated with epidermal growth factor receptor-inhibitor treatment.
White KJ; Roydhouse JK; Scott K
Clin J Oncol Nurs; 2011 Feb; 15(1):88-96. PubMed ID: 21278044
[TBL] [Abstract][Full Text] [Related]
19. Autologous stem cell transplant plus interleukin-2 for breast cancer: review and nursing management.
Foelber R
Oncol Nurs Forum; 1998 Apr; 25(3):563-8. PubMed ID: 9568611
[TBL] [Abstract][Full Text] [Related]
20. Neurologic protection by amifostine.
DiPaola RS; Schuchter L
Semin Oncol; 1999 Apr; 26(2 Suppl 7):82-8. PubMed ID: 10348265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
